130 related articles for article (PubMed ID: 31892561)
1. PTC209, a Specific Inhibitor of BMI1, Promotes Cell Cycle Arrest and Apoptosis in Cervical Cancer Cell Lines.
Li J; Vangundy Z; Poi M
Anticancer Res; 2020 Jan; 40(1):133-141. PubMed ID: 31892561
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation.
Srinivasan M; Bharali DJ; Sudha T; Khedr M; Guest I; Sell S; Glinsky GV; Mousa SA
Oncotarget; 2017 Jun; 8(24):38731-38742. PubMed ID: 28418883
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
Luo HB; Li B; Yuan WG; Xu CR
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
[TBL] [Abstract][Full Text] [Related]
4. Aberrantly elevated Bmi1 promotes cervical cancer tumorigenicity and tumor sphere formation via enhanced transcriptional regulation of Sox2 genes.
Xu R; Chen L; Yang WT
Oncol Rep; 2019 Aug; 42(2):688-696. PubMed ID: 31173263
[TBL] [Abstract][Full Text] [Related]
5. The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells.
Mayr C; Wagner A; Loeffelberger M; Bruckner D; Jakab M; Berr F; Di Fazio P; Ocker M; Neureiter D; Pichler M; Kiesslich T
Oncotarget; 2016 Jan; 7(1):745-58. PubMed ID: 26623561
[TBL] [Abstract][Full Text] [Related]
6. Alantolactone inhibits cervical cancer progression by downregulating BMI1.
Sun X; Xu H; Dai T; Xie L; Zhao Q; Hao X; Sun Y; Wang X; Jiang N; Sang M
Sci Rep; 2021 Apr; 11(1):9251. PubMed ID: 33927214
[TBL] [Abstract][Full Text] [Related]
7. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
[TBL] [Abstract][Full Text] [Related]
8. Fas signaling induces stemness properties in colorectal cancer by regulation of Bmi1.
Chen J; Wang Y; Zhuo L; Liu Z; Liu T; Li W; Cai Y; Zheng H
Mol Carcinog; 2017 Oct; 56(10):2267-2278. PubMed ID: 28543447
[TBL] [Abstract][Full Text] [Related]
9. Validation of Bmi1 as a therapeutic target of hepatocellular carcinoma in mice.
Qi S; Li B; Yang T; Liu Y; Cao S; He X; Zhang P; Li L; Xu C
Int J Mol Sci; 2014 Nov; 15(11):20004-21. PubMed ID: 25372945
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.
Teshima K; Nara M; Watanabe A; Ito M; Ikeda S; Hatano Y; Oshima K; Seto M; Sawada K; Tagawa H
Oncogene; 2014 Apr; 33(17):2191-203. PubMed ID: 23686310
[TBL] [Abstract][Full Text] [Related]
11. PI3K/AKT pathway-mediated regulation of p27(Kip1) is associated with cell cycle arrest and apoptosis in cervical cancer.
Prasad SB; Yadav SS; Das M; Modi A; Kumari S; Pandey LK; Singh S; Pradhan S; Narayan G
Cell Oncol (Dordr); 2015 Jun; 38(3):215-25. PubMed ID: 25821107
[TBL] [Abstract][Full Text] [Related]
12. Silencing of Bmi-1 gene enhances chemotherapy sensitivity in human glioblastoma cells.
Hong Y; Shang C; Xue YX; Liu YH
Med Sci Monit; 2015 Apr; 21():1002-7. PubMed ID: 25858624
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells.
Zhu D; Wan X; Huang H; Chen X; Liang W; Zhao F; Lin T; Han J; Xie W
Oncol Rep; 2014 Feb; 31(2):727-36. PubMed ID: 24337040
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA‑128a, BMI1 polycomb ring finger oncogene, and reactive oxygen species inhibit the growth of U‑87 MG glioblastoma cells following exposure to X‑ray radiation.
Ye L; Yu G; Wang C; Du B; Sun D; Liu J; Qi T; Yu X; Wei W; Cheng J; Jiang Y
Mol Med Rep; 2015 Oct; 12(4):6247-54. PubMed ID: 26238021
[TBL] [Abstract][Full Text] [Related]
15. A genome-wide enrichment screen identifies NUMA1-loss as a resistance mechanism against mitotic cell-death induced by BMI1 inhibition.
Gisler S; Maia ARR; Chandrasekaran G; Kopparam J; van Lohuizen M
PLoS One; 2020; 15(4):e0227592. PubMed ID: 32343689
[TBL] [Abstract][Full Text] [Related]
16. Disulfiram/Copper Suppresses Cancer Stem Cell Activity in Differentiated Thyroid Cancer Cells by Inhibiting BMI1 Expression.
Ni YL; Chien PJ; Hsieh HC; Shen HT; Lee HT; Chen SM; Chang WW
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362068
[TBL] [Abstract][Full Text] [Related]
17. Myricetin and methyl eugenol combination enhances the anticancer activity, cell cycle arrest and apoptosis induction of cis-platin against HeLa cervical cancer cell lines.
Yi JL; Shi S; Shen YL; Wang L; Chen HY; Zhu J; Ding Y
Int J Clin Exp Pathol; 2015; 8(2):1116-27. PubMed ID: 25972998
[TBL] [Abstract][Full Text] [Related]
18. BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer.
M JR; S V
Gene; 2018 Dec; 678():302-311. PubMed ID: 30096458
[TBL] [Abstract][Full Text] [Related]
19. BMI1 Inhibitors Down-regulate NOTCH Signaling and Suppress Proliferation of Acute Leukemia Cells.
Ohtaka M; Itoh M; Tohda S
Anticancer Res; 2017 Nov; 37(11):6047-6053. PubMed ID: 29061784
[TBL] [Abstract][Full Text] [Related]
20. Diallyl sulfide promotes cell-cycle arrest through the p53 expression and triggers induction of apoptosis via caspase- and mitochondria-dependent signaling pathways in human cervical cancer Ca Ski cells.
Chiu TH; Lan KY; Yang MD; Lin JJ; Hsia TC; Wu CT; Yang JS; Chueh FS; Chung JG
Nutr Cancer; 2013; 65(3):505-14. PubMed ID: 23530650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
